272 related articles for article (PubMed ID: 19854869)
1. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
Shevalye H; Stavniichuk R; Xu W; Zhang J; Lupachyk S; Maksimchyk Y; Drel VR; Floyd EZ; Slusher B; Obrosova IG
Biochem Pharmacol; 2010 Apr; 79(7):1007-14. PubMed ID: 19945439
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.
Drel VR; Lupachyk S; Shevalye H; Vareniuk I; Xu W; Zhang J; Delamere NA; Shahidullah M; Slusher B; Obrosova IG
Endocrinology; 2010 Jun; 151(6):2547-55. PubMed ID: 20357221
[TBL] [Abstract][Full Text] [Related]
5. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation.
Minchenko AG; Stevens MJ; White L; Abatan OI; Komjáti K; Pacher P; Szabó C; Obrosova IG
FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.
Drel VR; Pacher P; Stavniichuk R; Xu W; Zhang J; Kuchmerovska TM; Slusher B; Obrosova IG
Int J Mol Med; 2011 Oct; 28(4):629-35. PubMed ID: 21617845
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.
Shevalye H; Maksimchyk Y; Watcho P; Obrosova IG
Biochim Biophys Acta; 2010 Nov; 1802(11):1020-7. PubMed ID: 20621183
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.
Drel VR; Pacher P; Stevens MJ; Obrosova IG
Free Radic Biol Med; 2006 Apr; 40(8):1454-65. PubMed ID: 16631535
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
[TBL] [Abstract][Full Text] [Related]
11. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.
Obrosova IG; Xu W; Lyzogubov VV; Ilnytska O; Mashtalir N; Vareniuk I; Pavlov IA; Zhang J; Slusher B; Drel VR
Free Radic Biol Med; 2008 Mar; 44(6):972-81. PubMed ID: 17976390
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.
Lupachyk S; Shevalye H; Maksimchyk Y; Drel VR; Obrosova IG
Free Radic Biol Med; 2011 May; 50(10):1400-9. PubMed ID: 21300148
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
[TBL] [Abstract][Full Text] [Related]
14. Tempol reduces podocyte apoptosis via PARP signaling pathway in experimental diabetes mellitus.
Peixoto EB; Papadimitriou A; Lopes de Faria JM; Lopes de Faria JB
Nephron Exp Nephrol; 2012; 120(2):e81-90. PubMed ID: 22555049
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.
Szabó C; Biser A; Benko R; Böttinger E; Suszták K
Diabetes; 2006 Nov; 55(11):3004-12. PubMed ID: 17065336
[TBL] [Abstract][Full Text] [Related]
16. Exposure to fluoride exacerbates the cognitive deficit of diabetic patients living in areas with endemic fluorosis, as well as of rats with type 2 diabetes induced by streptozotocin via a mechanism that may involve excessive activation of the poly(ADP ribose) polymerase-1/P53 pathway.
Xiang J; Qi XL; Cao K; Ran LY; Zeng XX; Xiao X; Liao W; He WW; Hong W; He Y; Guan ZZ
Sci Total Environ; 2024 Feb; 912():169512. PubMed ID: 38145685
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-Ribose) Polymerase Inhibition Improves Corneal Epithelial Innervation and Wound Healing in Diabetic Rats.
Byun YS; Kang B; Yoo YS; Joo CK
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1948-55. PubMed ID: 25711635
[TBL] [Abstract][Full Text] [Related]
19. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
